• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于区分帕金森病患者与无多巴胺能缺陷证据受试者的项目反应模型和人工神经网络

Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.

作者信息

Arrington Leticia, van Dijkman Sven C, Plan Elodie L, Karlsson Mats O

机构信息

Department of Pharmacy, Uppsala University, Uppsala, Sweden.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2025 May;14(5):881-890. doi: 10.1002/psp4.70000. Epub 2025 Mar 5.

DOI:10.1002/psp4.70000
PMID:40045658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072227/
Abstract

Approximately 15% of patients suspected of having Parkinson's disease (PD) present dopamine active transporter (DaT) scans without evidence of dopaminergic deficits (SWEDD), most of which will never develop PD. Leveraging Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores from the Parkinson's Progression Markers Initiative, three different models of varying complexity, (total score, item response theory (IRT) and artificial neural network (ANN)) were evaluated to determine their ability to differentiate between PD and SWEDDs. Each of the models provided as output a predicted probability of having PD (P). Both the IRT and ANN methods performed well as classifiers; ROC AUC > 80%, sensitivity > 93%, and precision ~90% when assuming a probability cutoff of P ≥ 50%. Specificity was 43% and 38% for IRT and ANN respectively. Matthews correlation coefficient (MCC) was also evaluated as a metric to address potential bias of majority positive class. At all cutoffs at or above 50%, the IRT and ANN model performed similarly and achieved a MCC of at least 0.3, indicating at least a moderate positive relationship for classifier performance. In contrast, the total score model was a poor classifier, for all metrics and cutoffs. Using item-level data the proposed methodologies differentiated PD patients from SWEDDs with a degree of sensitivity and specificity that may compete with clinical examination and could aid in selecting DaTscan candidates. The choice of cutoff criteria, quality metric, and classifier model are contingent upon specific clinical needs.

摘要

约15%疑似帕金森病(PD)的患者进行多巴胺活性转运体(DaT)扫描时未发现多巴胺能缺陷证据(SWEDD),其中大多数患者永远不会发展为PD。利用帕金森病进展标志物倡议中的运动障碍协会统一帕金森病评定量表(MDS-UPDRS)评分,评估了三种不同复杂度的模型(总分、项目反应理论(IRT)和人工神经网络(ANN))区分PD和SWEDD的能力。每个模型输出的是患PD的预测概率(P)。IRT和ANN方法作为分类器表现良好;当假设概率临界值P≥50%时,ROC曲线下面积>80%,灵敏度>93%,精确度约为90%。IRT和ANN的特异性分别为43%和38%。马修斯相关系数(MCC)也作为一种指标进行评估,以解决多数阳性类别的潜在偏差。在所有50%及以上的临界值下,IRT和ANN模型表现相似,MCC至少为0.3,表明分类器性能至少有中度正相关关系。相比之下,总分模型在所有指标和临界值下都是较差的分类器。使用项目级数据,所提出的方法以一定程度的灵敏度和特异性区分了PD患者和SWEDD患者,其程度可能与临床检查相当,并有助于选择DaT扫描候选者。临界标准、质量指标和分类器模型的选择取决于特定的临床需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/7f9181e7bb76/PSP4-14-881-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/70309ec04dff/PSP4-14-881-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/4a81d26fc33d/PSP4-14-881-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/db2597bb4dba/PSP4-14-881-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/7f9181e7bb76/PSP4-14-881-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/70309ec04dff/PSP4-14-881-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/4a81d26fc33d/PSP4-14-881-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/db2597bb4dba/PSP4-14-881-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a9/12072227/7f9181e7bb76/PSP4-14-881-g002.jpg

相似文献

1
Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit.用于区分帕金森病患者与无多巴胺能缺陷证据受试者的项目反应模型和人工神经网络
CPT Pharmacometrics Syst Pharmacol. 2025 May;14(5):881-890. doi: 10.1002/psp4.70000. Epub 2025 Mar 5.
2
Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD).扫描未见多巴胺能缺陷患者的临床特征的价值(SWEDD)。
J Parkinsons Dis. 2020;10(4):1561-1569. doi: 10.3233/JPD-202090.
3
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.使用基线和 1 年变化指标预测帕金森病的进展。
J Parkinsons Dis. 2019;9(4):665-679. doi: 10.3233/JPD-181518.
4
Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease.帕金森病中功能连接变化和纹状体多巴胺缺乏的动态特性。
Hum Brain Mapp. 2024 Jul 15;45(10):e26776. doi: 10.1002/hbm.26776.
5
Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.便秘与早期未经药物治疗的帕金森病患者的多巴胺转运体病理无关。
Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.
6
Explainable machine learning with pairwise interactions for the classification of Parkinson's disease and SWEDD from clinical and imaging features.基于两两交互的可解释机器学习在帕金森病和 SWEDD 的临床和影像特征分类中的应用。
Brain Imaging Behav. 2022 Oct;16(5):2188-2198. doi: 10.1007/s11682-022-00688-9. Epub 2022 May 26.
7
Machine learning for predicting cognitive decline within five years in Parkinson's disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers.用于预测帕金森病患者五年内认知衰退的机器学习:认知评估量表与多巴胺转运体单光子发射计算机断层扫描及临床生物标志物的比较
PLoS One. 2024 Jul 17;19(7):e0304355. doi: 10.1371/journal.pone.0304355. eCollection 2024.
8
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.早期帕金森病临床和生物学指标的纵向变化:帕金森进展标志物倡议队列。
Mov Disord. 2018 May;33(5):771-782. doi: 10.1002/mds.27361. Epub 2018 Mar 23.
9
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.帕金森进展标志物倡议(PPMI)中无明显 LRRK2 和 GBA 突变携带者的临床和多巴胺转运体成像特征:一项横断面研究。
Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31.
10
Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease.纹状体多巴胺转运体结合与早期帕金森病运动和非运动症状的关联。
Clin Transl Sci. 2023 Jun;16(6):1021-1038. doi: 10.1111/cts.13508. Epub 2023 Mar 23.

本文引用的文献

1
The Matthews correlation coefficient (MCC) should replace the ROC AUC as the standard metric for assessing binary classification.马修斯相关系数(MCC)应取代受试者工作特征曲线下面积(ROC AUC),作为评估二元分类的标准指标。
BioData Min. 2023 Feb 17;16(1):4. doi: 10.1186/s13040-023-00322-4.
2
Explainable machine learning with pairwise interactions for the classification of Parkinson's disease and SWEDD from clinical and imaging features.基于两两交互的可解释机器学习在帕金森病和 SWEDD 的临床和影像特征分类中的应用。
Brain Imaging Behav. 2022 Oct;16(5):2188-2198. doi: 10.1007/s11682-022-00688-9. Epub 2022 May 26.
3
Predicting Parkinson's Disease Progression: Evaluation of Ensemble Methods in Machine Learning.
预测帕金森病进展:机器学习中集成方法的评估。
J Healthc Eng. 2022 Feb 3;2022:2793361. doi: 10.1155/2022/2793361. eCollection 2022.
4
Performance of longitudinal item response theory models in shortened or partial assessments.在缩短或部分评估中纵向项目反应理论模型的性能。
J Pharmacokinet Pharmacodyn. 2020 Oct;47(5):461-471. doi: 10.1007/s10928-020-09697-x. Epub 2020 Jul 2.
5
The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation.马修斯相关系数(MCC)在二分类评估中优于 F1 得分和准确率的优势。
BMC Genomics. 2020 Jan 2;21(1):6. doi: 10.1186/s12864-019-6413-7.
6
Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications.帕金森病中的多巴胺转运体成像:抗帕金森药物治疗后的进展性变化及治疗调整
Intern Med. 2019 Jun 15;58(12):1665-1672. doi: 10.2169/internalmedicine.2489-18. Epub 2019 Feb 25.
7
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.帕金森病进展标志物计划(PPMI)——建立帕金森病生物标志物队列。
Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477. doi: 10.1002/acn3.644. eCollection 2018 Dec.
8
Correlation Coefficients: Appropriate Use and Interpretation.相关系数:合理使用与解释。
Anesth Analg. 2018 May;126(5):1763-1768. doi: 10.1213/ANE.0000000000002864.
9
Item Response Theory as an Efficient Tool to Describe a Heterogeneous Clinical Rating Scale in De Novo Idiopathic Parkinson's Disease Patients.项目反应理论作为一种有效的工具,可用于描述初发性特发性帕金森病患者中具有异质性的临床评分量表。
Pharm Res. 2017 Oct;34(10):2109-2118. doi: 10.1007/s11095-017-2216-1. Epub 2017 Jul 10.
10
Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in Schizophrenia.运用项目反应理论量化纵向安慰剂和帕利哌酮对精神分裂症患者阳性和阴性症状量表(PANSS)评分的影响。
CPT Pharmacometrics Syst Pharmacol. 2017 Aug;6(8):543-551. doi: 10.1002/psp4.12207. Epub 2017 Jul 13.